PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30221055-2	2018	Here, we report that the mTORC1/2 dual kinase inhibitor vistusertib (AZD2014) potentiates anti-tumour immunity in combination with anti-CTLA-4 (alphaCTLA-4), alphaPD-1 or alphaPD-L1 immune checkpoint blockade.	vistusertib	56-67	cytotoxic T-lymphocyte associated protein 4	Homo sapiens	136-142